Is It Perimenopause? Common Symptoms and What Can Help
Perimenopause can start years before your last period. Here's what's changing, the symptoms it can bring, and the treatments with real evidence behind them.
Read the articleHeadlines from 2002 still shape how many women feel about hormone therapy. Two decades of follow-up have given a clearer, more nuanced picture.
Few medical topics have whiplashed women as much as menopausal hormone therapy. In the 1990s it was widely prescribed. In 2002, early results from the Women's Health Initiative (WHI) made headlines, and many women stopped overnight. Since then, researchers have spent two decades working out what those results did and did not mean.
The WHI hormone trials enrolled postmenopausal women with an average age of 63, many of them well past the menopause transition. The estrogen-plus-progestin trial was stopped early after higher rates of breast cancer, heart events, stroke and blood clots were seen in the hormone group. Use of hormone therapy fell sharply around the world.
What got less attention was that most women in the trial were older than the women who usually seek treatment for hot flashes, and that risks and benefits differed by age.
In 2017, WHI investigators reported on women followed for a median of about 18 years. Deaths from any cause were essentially the same in the hormone and placebo groups: 27.1% compared with 27.6%.[1] Hormone therapy did not increase or decrease the overall risk of dying over that time.
That finding doesn't make hormone therapy risk-free. It shows that the risks are specific and measurable, and that they depend on who is taking it, when, and in what form.
The Menopause Society's 2022 position statement sets out the current consensus.[2]
Women who reach menopause before 40, or before 45, lose estrogen's protection for bones and heart years earlier than average. Unless there's a reason not to, hormone therapy is generally advised at least until the average age of natural menopause.[3]
This matters for BRCA carriers who have their ovaries and tubes removed to lower cancer risk. ACOG advises offering hormone therapy after this surgery to women who have not had breast cancer, noting that limited data suggest short-term use does not meaningfully reduce the surgery's protective benefit.[4]
Examples include a history of breast cancer or another estrogen-sensitive cancer, a prior blood clot or stroke, active liver disease, coronary heart disease, and unexplained vaginal bleeding. This is not a complete list, and some situations are gray areas that need individual discussion. For many women in these groups, nonhormone treatments are effective alternatives.
A good hormone therapy conversation covers your symptoms and how much they affect you, your personal and family history, your risk of heart disease, breast cancer and osteoporosis, and your own preferences. The goal isn't to talk you into or out of anything. It's to give you accurate numbers in context, so the choice you make is your own.
It's also a decision you can revisit. Many women start at a low dose, check in after a few months, and adjust. If symptoms change, if a new diagnosis comes up, or if you simply want to try stopping, the conversation reopens. Stopping is usually done gradually or simply, depending on what you're taking, and some women find their symptoms return. Neither choice is permanent, and neither is a failure.
Talk with a clinician before starting or stopping hormone therapy. Get prompt care for unexpected vaginal bleeding, a new breast lump, leg swelling or pain, or sudden shortness of breath. Call 911 for chest pain or signs of stroke.
This article is general education for adults and is not a substitute for personal medical advice. If you have a medical emergency, call 911.
Perimenopause can start years before your last period. Here's what's changing, the symptoms it can bring, and the treatments with real evidence behind them.
Read the articleCancer treatment can bring menopause on suddenly, and endocrine therapy can make symptoms stronger. Here are the options that fit a survivor's life.
Read the articleGenitourinary syndrome of menopause affects a large share of postmenopausal women, yet many never mention it. Here's what it is and how it's treated.
Read the article